Tumor necrosis factor-alpha (TNF-α) inhibitors are commonly used for management of various autoimmune disorders but can rarely cause isolated cutaneous lupus. This report presents two cases of cutaneous lupus erythematosus (LE) in women aged 38 and 61 after adalimumab treatment for psoriasis highlighting the importance of recognizing these paradoxical reactions for timely management.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732697 | PMC |
| http://dx.doi.org/10.1002/ccr3.70115 | DOI Listing |
Publication Analysis
Top Keywords
cutaneous lupus
12
lupus erythematosus
8
adalimumab-induced cutaneous
4
erythematosus cases
4
cases presenting
4
presenting malar
4
malar rash
4
rash panniculitis
4
panniculitis tumor
4
tumor necrosis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!